Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Stoughton, MA
SEC filing record 1 source field available
Fiscal year end
31 December
COLLEGIUM PHARMACEUTICAL, INC has filed 826 SEC EDGAR filings since 20 Oct 2003

SEC filing history

Showing 551-575 of 820 matching filings.

Per page
25
Current page
23
SC 13G/A File 005-88843

SC 13G/A filing

Filing date
04 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Jan 2019
Reporting date
25 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88843

SC 13G filing

Filing date
25 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2019
Reporting date
18 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2019
Reporting date
18 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Jan 2019
Reporting date
18 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Jan 2019
Reporting date
15 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37372

8-K

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Dec 2018
Reporting date
30 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Nov 2018
Reporting date
15 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Nov 2018
Reporting date
14 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-325594

D filing

Filing date
13 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37372

8-K

Filing date
08 Nov 2018
Reporting date
08 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Oct 2018
Reporting date
15 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Aug 2018
Reporting date
23 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Aug 2018
Reporting date
23 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Aug 2018
Reporting date
23 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37372

8-K

Filing date
08 Aug 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .